JP2012193207A - インターフェロンを用いる肺疾患の処置方法 - Google Patents

インターフェロンを用いる肺疾患の処置方法 Download PDF

Info

Publication number
JP2012193207A
JP2012193207A JP2012157469A JP2012157469A JP2012193207A JP 2012193207 A JP2012193207 A JP 2012193207A JP 2012157469 A JP2012157469 A JP 2012157469A JP 2012157469 A JP2012157469 A JP 2012157469A JP 2012193207 A JP2012193207 A JP 2012193207A
Authority
JP
Japan
Prior art keywords
patients
interferon
treatment
ifn
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012157469A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012193207A5 (enExample
Inventor
Rany Condos
コンドス ラニー
Gerald Smaldone
スマルドン ジェラルド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University
Research Foundation of the State University of New York
Original Assignee
New York University
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University, Research Foundation of the State University of New York filed Critical New York University
Priority to JP2012157469A priority Critical patent/JP2012193207A/ja
Publication of JP2012193207A publication Critical patent/JP2012193207A/ja
Publication of JP2012193207A5 publication Critical patent/JP2012193207A5/ja
Withdrawn legal-status Critical Current

Links

Images

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2012157469A 2012-07-13 2012-07-13 インターフェロンを用いる肺疾患の処置方法 Withdrawn JP2012193207A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012157469A JP2012193207A (ja) 2012-07-13 2012-07-13 インターフェロンを用いる肺疾患の処置方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012157469A JP2012193207A (ja) 2012-07-13 2012-07-13 インターフェロンを用いる肺疾患の処置方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008532198A Division JP5175198B2 (ja) 2005-09-20 2005-09-20 インターフェロンを用いる肺疾患の処置方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014258344A Division JP2015057446A (ja) 2014-12-22 2014-12-22 インターフェロンを用いる肺疾患の処置方法

Publications (2)

Publication Number Publication Date
JP2012193207A true JP2012193207A (ja) 2012-10-11
JP2012193207A5 JP2012193207A5 (enExample) 2013-01-10

Family

ID=47085448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012157469A Withdrawn JP2012193207A (ja) 2012-07-13 2012-07-13 インターフェロンを用いる肺疾患の処置方法

Country Status (1)

Country Link
JP (1) JP2012193207A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116251174A (zh) * 2022-12-23 2023-06-13 北京三元基因药业股份有限公司 一种包含人干扰素α1b吸入溶液的药物组件

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003519169A (ja) * 1999-12-30 2003-06-17 インターミューン インコーポレイテッド γ−ＩＦＮ液滴エアロゾルおよび方法
WO2004004656A2 (en) * 2002-07-03 2004-01-15 The Kenneth S. Warren Institute, Inc. Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
JP2004529122A (ja) * 2001-03-19 2004-09-24 モナシュ ユニバーシティ 呼吸器系病態の治療法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003519169A (ja) * 1999-12-30 2003-06-17 インターミューン インコーポレイテッド γ−ＩＦＮ液滴エアロゾルおよび方法
JP2004529122A (ja) * 2001-03-19 2004-09-24 モナシュ ユニバーシティ 呼吸器系病態の治療法
WO2004004656A2 (en) * 2002-07-03 2004-01-15 The Kenneth S. Warren Institute, Inc. Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116251174A (zh) * 2022-12-23 2023-06-13 北京三元基因药业股份有限公司 一种包含人干扰素α1b吸入溶液的药物组件
CN116251174B (zh) * 2022-12-23 2023-09-29 北京三元基因药业股份有限公司 一种包含人干扰素α1b吸入溶液的药物组件

Similar Documents

Publication Publication Date Title
US20120148532A1 (en) Method of treating pulmonary disease with interferons
Keatings et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Wylam et al. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis
Borish et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma
Tanaka et al. IL-18 might reflect disease activity in mild and moderate asthma exacerbation
Stirling et al. Interleukin-5 induces CD34+ eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma
Panina-Bordignon et al. The CC chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics
Flood-Page et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
Van Scott et al. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice
Shi et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
US20090123422A1 (en) Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y
CN103328506A (zh) 用于改善肺功能的疗法
D'Armiento et al. Eosinophil and T cell markers predict functional decline in COPD patients
Ikeda et al. Resolution of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and corticosteroids
Tenero et al. Effect of montelukast on markers of airway remodeling in children with asthma.
Taube et al. Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness
Shioya et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma
JP5175198B2 (ja) インターフェロンを用いる肺疾患の処置方法
EP1922081B1 (en) Interferon lambda therapy for treatment of respiratory diseases
US8486383B2 (en) Method of treating pulmonary disease with interferons
JP2015057446A (ja) インターフェロンを用いる肺疾患の処置方法
KR20080093016A (ko) 인터페론을 사용하여 폐질환을 치료하는 방법
CN103550757A (zh) 用干扰素治疗肺病的方法
Král et al. Some serum activity markers of airways inflammation in difficult-to-control asthma patients
Xue et al. Up-regulation of CD44 expression by interleukin-13 in a murine model of asthma

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120713

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140122

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140418

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140821

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141222

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150204

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150227

A912 Removal of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20150410

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160310

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160408

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160509

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160523

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20161221